System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Hervé Maillard is an expert in Dermatology at Centre Hospitalier du Mans (France). Hervé Maillard has authored 221 publications, the most recent in 2026, and is an investigator in 13 clinical trials, 5 of them ongoing. SLR score: 683 (community average: 125). How the SLR is computed.

LeadR Profile

Hervé Maillard Centre Hospitalier du Mans France
683 ScienceLeadR Reputation 683

Unlock

Register Login
Network Map

Dermatology

Subspecialties: Immunology - Oncology - Hematology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1995 - 2026
Source: PubMed

Centre Hospitalier - Le Mans

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 221

Citations

Citations: 3 836 1st author: 15 Last author: 43 Unique author: 7

Main journals

Ann Dermatol Venereol 80
Rev Med Interne 11
J Am Acad Dermatol 10
Acta Derm Venereol 8
J Eur Acad Dermatol Venereol 7

Best Journals

Lancet 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Multiple Eruptive Facial Tumours in a 72-year-old Man Receiving Pembrolizumab: A Quiz.
PMID 42813742 — sexually transmitted diseases, dermatology		Acta Derm Venereol20260
A New Phototherapy Regimen Coupled with Oral Vitamin D Supplementation, for the Long-Term Control of Atopic Dermatitis: A French Multicenter, Randomized, Crossover, Pragmatic Trial.
PMID 42728529 — vitamin d, dermatitis, vitamins, phototherapy, genes, tat, therapeutics, dermatitis, atopic		Dermatol Ther (Heidelb)20260
Berotralstat Tolerability and Effectiveness in Hereditary Angioedema: Berolife Study Results.
PMID 42603305 — pain, angioedemas, hereditary, therapeutics, angioedema, abdominal pain		Clin Transl Allergy20260
Tocilizumab for severe and refractory mucous membrane pemphigoid.
PMID 42200380 — cytokines, sexually transmitted diseases, serum, skin diseases, pemphigoid, bullous, proteomics, mucous membrane, membranes		J Eur Acad Dermatol Venereol20260
Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA.
PMID 41806521 — cells, safety, carcinoma, squamous cell, neoplasms, therapeutics		Eur J Cancer20260

Clinical Studies 13

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4

By phase:

N/A 5
Phase 3 4
Phase 2 2
Phase 4 2

By status:

Recruiting 5
Completed 4
Active not recruiting 1
Not yet recruiting 1
Terminated 1
Unknown 1

By type:

Interventional 10
Observational 3

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 2
multicentric5to9 0
multicentricup10 9

Main Topics

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Prophylaxis of Recurrent Erysipelas in Lower Limbs compreSsion thErapy vs aNTibiotics and Compression Therapy
NCT07549594 — nurses, research design, cellulitis, telemedicine, emollients, erysipelas, penicillin v, therapeutics, random allocation, infections, stockings, compression, male		Phase 4Not yet recruiting2026
Efficacy and Tolerance of the Association of ANIFROLUMAB (300mg) IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo
NCT05917561 — vitiligo, phototherapy		Phase 2Recruiting2023
Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus
NCT05898308 — injections, skin, antibodies, adrenal cortex hormones, skin diseases, desmogleins, biomarkers, maintenance, rituximab, precision medicine, acantholysis, therapeutics, pemphigus		Phase 4Recruiting2024
Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia
NCT05641142 — hemoglobins, epistaxis, quality of life, anticoagulants, hemorrhage, hospitalization, telangiectasia, hereditary hemorrhagic, telangiectasis, ferritins, therapeutics, accidents, prospective studies		N/ARecruiting2023
Constitution of a Prospective Cohort of Patients With Acute Suppurative Hidrosadenitis Followed in the Great West the COVER Cohort (Verneuil Cohort)
NCT04352036 — phenotype, hidradenitis		N/ARecruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS